Literature DB >> 30983026

Effect of selenium and pentoxifylline on expression of CATSPER1 and 2 genes and FSH/LH levels in treated mice by dexamethasone.

Nasrin Kheradmand1, Razieh Kamkar2, Minoo Moshajjari3, Maryam Baazm4.   

Abstract

Dexamethasone has deleterious effects on male fertility and sperm parameters. In this study, the effect of dexamethasone on expression of CATSPER1 and 2 genes was investigated. These two genes play an important role in sperm motility. Selenium and pentoxifylline were subsequently used to protect testis tissue against the destructive effects of dexamethasone. Each group received one of the following treatments for 7 days: dexamethasone (7 mg/kg), pentoxifylline (200 mg/kg), selenium (0.3 mg/kg), dexamethasone + pentoxifylline or selenium + dexamethasone. Animals in the control group received a normal saline injection. The expression of CATSPER1 and 2 genes was analysed by real-time PCR and serum levels of FSH and LH were determined with the enzyme-linked immunosorbent assay method. Based on the results, dexamethasone decreases not only CATSPER1 and 2 gene expression but also serum levels of LH (p ≤ 0.05); however, it has no effect on FSH (p > 0.05). Treating with selenium significantly increased the gene expression of both CATSPER1 and 2 (p ≤ 0.05), while pentoxifylline enhanced only CATSPER2 gene expression (p ≤ 0.05). These two antioxidants were shown to increase serum levels of LH (p ≤ 0.05). Our data suggest that selenium is more effective than pentoxifylline in overcoming adverse effects of dexamethasone on male fertility.
© 2019 Blackwell Verlag GmbH.

Entities:  

Keywords:  CATSPER; dexamethasone; pentoxifylline; selenium

Year:  2019        PMID: 30983026     DOI: 10.1111/and.13279

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  1 in total

1.  Up-regulation of Arl4a gene expression by broccoli aqueous extract is associated with improved spermatogenesis in mouse testes.

Authors:  Omid Jazayeri; Setareh Farahmand Araghi; Tahereh A Aghajanzadeh; Fereshteh Mir Moammadrezaei
Journal:  Biomedica       Date:  2021-12-15       Impact factor: 0.935

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.